History People Scholarships Past Presentations

About BASS

Past Presentations

Select Conference Year
Past Conferences

2012

Session Speaker Presentation
M-1 Russell Reeve Model-Based Drug Development
M-2 Jeffrey Morris Modeling High-Dimensional Functioning and Image Data
M-3 Ying Yuan Bayesian Optimal Interval Design for Phase I Clinical Trials
M-4 Roy Sabo A Bayesian Adaptive Allocation Method for Clinical Trials with Dual Objectives
M-5 Cory Heilmann Use of Bayesian Evidence Synthesis Techniques Across Phases of Drug Development
M-6 Doug Faries Comparative Effectiveness Analysis from Observational Data
M-7 Joe Cappelleri Network Meta-Analysis for Comparative Effectiveness Research
M-8 Susan Duke Graphs are Statistical Methods Too! The Case for Graphics in Safety and Benefit-Risk Analysis
Keynote Address Christy Chuang-Stein Career in Pharmaceutical Industry: Exciting, Challenging and Rewarding
T-1 Melvin Munsaka Statistical Analysis of Safety Data - A Survey of Some Analysis Methods
T-2 Frank Rockhold Enhancing the Way We Quantify and Communicate Benefit to Risk in the Pre and Post Approval Arena
T-3 Jesse Berlin Opportunities and Challenges for Using Networks of Observational Healthcare Data for Medical Product Safety Surveillance
T-4 Zhenzhen Xu Propensity Scoring Matching in Cluster Randomized Trials
T-5 Xiaolong Luo A Multiple Comparison Procedure for Hypotheses with Gatekeeping Structures
T-6 Colleen Twomey 21st Century Drug Development: The Road to Consistency and Transparency
W-1 Aloka Chakravarty Quantitative Safety Evaluation at CDER
W-2 Estelle Russek-Cohen Safety Throughout the Life Cycle of Vaccines
W-3 Mark Levenson Quantitative Safety Assessment During the Post-Marketing Phase: Examples at FDA/CDER
W-4 Christy Chuang-Stein Safety Assessment of Pharmaceutical Products